OPKO Health (OPK) Competitors

OPKO Health (NASDAQ:OPK) and Innoviva (NASDAQ:INVA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk, community ranking, media sentiment and profitability.

Which has more volatility and risk, OPK or INVA?

OPKO Health has a beta of 1.82, meaning that its share price is 82% more volatile than the S&P 500. Comparatively, Innoviva has a beta of 0.57, meaning that its share price is 43% less volatile than the S&P 500.

Which has preferable earnings and valuation, OPK or INVA?

Innoviva has lower revenue, but higher earnings than OPKO Health. OPKO Health is trading at a lower price-to-earnings ratio than Innoviva, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OPKO Health	$863.50M	1.02	-$188.86M	-$0.25	-5.04
Innoviva	$310.46M	3.11	$179.72M	$2.18	7.00

Is OPK or INVA more profitable?

Innoviva has a net margin of 57.89% compared to OPKO Health's net margin of -21.76%. Innoviva's return on equity of 30.37% beat OPKO Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OPKO Health	-21.76%	-12.69%	-8.95%
Innoviva	57.89%	30.37%	15.70%

Do insiders & institutionals have more ownership in OPK or INVA?

64.6% of OPKO Health shares are owned by institutional investors. Comparatively, 99.1% of Innoviva shares are owned by institutional investors. 47.3% of OPKO Health shares are owned by company insiders. Comparatively, 1.4% of Innoviva shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Does the MarketBeat Community prefer OPK or INVA?

OPKO Health received 202 more outperform votes than Innoviva when rated by MarketBeat users. Likewise, 65.83% of users gave OPKO Health an outperform vote while only 57.28% of users gave Innoviva an outperform vote.

Company	Underperform	Outperform
OPKO Health	Outperform Votes 497 65.83%	Underperform Votes 258 34.17%
Innoviva	Outperform Votes 295 57.28%	Underperform Votes 220 42.72%

Does the media prefer OPK or INVA?

In the previous week, Innoviva had 1 more articles in the media than OPKO Health. MarketBeat recorded 5 mentions for Innoviva and 4 mentions for OPKO Health. Innoviva's average media sentiment score of 1.03 beat OPKO Health's score of 0.88 indicating that Innoviva is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OPKO Health	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Innoviva	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts rate OPK or INVA?

OPKO Health currently has a consensus target price of $3.73, indicating a potential upside of 195.63%. Given OPKO Health's higher possible upside, research analysts plainly believe OPKO Health is more favorable than Innoviva.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OPKO Health	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Innoviva	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Summary

Innoviva beats OPKO Health on 10 of the 17 factors compared between the two stocks.